Roche
RO.SW
#32
Rank
NZ$692.41 B
Marketcap
NZ$869.03
Share price
0.25%
Change (1 day)
40.54%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2022: NZ$30.09

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$36.60. In 2022 the company made an earnings per share (EPS) of NZ$30.09 a decrease over its 2021 EPS that were of NZ$32.11.

EPS history for Roche from 1998 to 2022

Annual EPS

Year EPS Change
2022NZ$30.09-6.29%
2021NZ$32.11-5.53%
2020NZ$33.9916.56%
2019NZ$29.1630.3%
2018NZ$22.3820.22%
2017NZ$18.61-5.81%
2016NZ$19.764.62%
2015NZ$18.89-5.13%
2014NZ$19.91-25.05%
2013NZ$26.5721.73%
2012NZ$21.823.82%
2011NZ$21.028.16%
2010NZ$19.4323.72%
2009NZ$15.71-12.31%
2008NZ$17.91-0.34%
2007NZ$17.9732.13%
2006NZ$13.6042.56%
2005NZ$9.54-22.7%
2004NZ$12.34132.85%
2003NZ$5.30-154.73%
2002NZ-$9.69-209.09%
2001NZ$8.88-57.25%
2000NZ$20.7754.06%
1999NZ$13.4831.24%
1998NZ$10.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.40-74.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.84-86.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$29.05-20.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41-90.69%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$6.45-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.78-95.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.15-85.92%๐Ÿ‡ฌ๐Ÿ‡ง UK